Advertisement

Virchows Archiv

, Volume 472, Issue 6, pp 907–917 | Cite as

Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens

Review and Perspectives

Abstract

Benign proliferations that mimic malignancies are commonly encountered during the course of assessment of small and fragmented endometrial samples. Although benign, endometrial epithelial metaplasias often coexist with premalignant or malignant lesions causing diagnostic confusion. The difficulty with mucinous metaplasia lies in its distinction from atypical mucinous glandular proliferations and mucinous carcinomas, which are associated with significant interobserver variability. Papillary proliferation of the endometrium is commonly associated with hormonal drugs and endometrial polyps and is characterised by papillae with fibrovascular cores covered by epithelial cells without cytologic atypia. They are classified into simple or complex papillary proliferations depending on the architectural complexity and extent of proliferation. Complex papillary proliferations are associated with a high risk of concurrent or subsequent hyperplasia with atypia/carcinoma. Papillary proliferations may have coexisting epithelial metaplasias and, most commonly, mucinous metaplasia and syncytial papillary change. Those with striking mucinous metaplasia overlap morphologically with papillary mucinous metaplasia. The latter has been proposed as a precursor of endometrial mucinous carcinoma. Misinterpreting the Arias-Stella reaction as a malignant or premalignant lesion is more likely to occur if the pathologist is unaware that the patient is pregnant or on hormonal drugs. Endometrial hyperplasia with secretory changes may occasionally be difficult to distinguish from the torturous and crowded glands of a late secretory endometrium. Endometrial polyps may have abnormal features that can be misinterpreted as endometrial hyperplasia or Mullerian adenosarcoma. Awareness of these benign endometrial proliferations and their common association with hormonal medication or altered endogenous hormonal levels will help prevent the over-diagnosis of premalignant and malignant lesions.

Keywords

Endometrium Papillary proliferation Mucinous Mucinous metaplasia Arias-Stella reaction Endometrial polyp Endometrial hyperplasia Mullerian adenosarcoma 

Notes

Acknowledgements

The author thanks Dr. Philip B. Clement who offered constructive criticism of the manuscript that was most helpful.

Compliance with ethical standards

Ethics approval

Ethics approval is not applicable to review article.

Conflict of interest

The author declares that there is no conflict of interest.

References

  1. 1.
    Demopoulos RI, Greco MA (1983) Mucinous metaplasia of the endometrium: ultrastructural and histochemical characteristics. Int J Gynecol Pathol 1:383–390CrossRefPubMedGoogle Scholar
  2. 2.
    Mikami Y, Kiyokawa T, Sasajima Y, Teramoto N, Wakasa T, Wakasa K, Hata S (2009) Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia. Histopathology 54:184–191CrossRefPubMedGoogle Scholar
  3. 3.
    Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH (2013) Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Am J Surg Pathol 37:167–177CrossRefPubMedGoogle Scholar
  4. 4.
    Hendrickson MR, Kempson RL (1980) Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 4:525–542CrossRefPubMedGoogle Scholar
  5. 5.
    Nicolae A, Goyenaga P, McCluggage WG, Preda O, Nogales FF (2011) Endometrial intestinal metaplasia: a report of two cases, including one associated with cervical intestinal and pyloric metaplasia. Int J Gynecol Pathol 30:492–496CrossRefPubMedGoogle Scholar
  6. 6.
    Nicolae A, Preda O, Nogales FF (2011) Endometrial metaplasias and reactive changes: a spectrum of altered differentiation. J Clin Pathol 64:97–106CrossRefPubMedGoogle Scholar
  7. 7.
    Alomari A, Abi-Raad R, Buza N, Hui P (2014) Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Mod Pathol 27:675–680CrossRefPubMedGoogle Scholar
  8. 8.
    Fujiwara M, Longacre TA (2011) Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol 35:537–544CrossRefPubMedGoogle Scholar
  9. 9.
    Nucci MR, Prasad CJ, Crum CP, Mutter GL (1999) Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol 12:1137–1142PubMedGoogle Scholar
  10. 10.
    Vang R, Tavassoli FA (2003) Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol 11:261–270CrossRefPubMedGoogle Scholar
  11. 11.
    Zaino RJ, Carinelli SG, Ellenson LH, Eng C, Katabuchi H, Konishi I, Lax S, Matias-Guiu X, Mutter GL, Peters WA III, Sherman ME, Shih I-M, Soslow RA, Stewart CJ (2014) Tumours of the uterine corpus. Epithelial tumours and precursors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs. IARC, Lyon, pp 125–135Google Scholar
  12. 12.
    Rawish KR, Desouki MM, Fadare O (2017) Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases. Hum Pathol 63:53–62CrossRefPubMedGoogle Scholar
  13. 13.
    He M, Jackson CL, Gubrod RB, Breese V, Steinhoff M, Lawrence WD, Xiong J (2015) KRAS mutations in mucinous lesions of the uterus. Am J Clin Pathol 143:778–784CrossRefPubMedGoogle Scholar
  14. 14.
    Yoo SH, Park BH, Choi J, Yoo J, Lee SW, Kim YM, Kim KR (2012) Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol 25:1496–1507CrossRefPubMedGoogle Scholar
  15. 15.
    Lehman MB, Hart WR (2001) Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol 25:1347–1354CrossRefPubMedGoogle Scholar
  16. 16.
    Miliaras D, Saravelos H, Miliaras S, Lagos S (1997) Papillary metaplasia and decidualisation of the endometrium in a woman receiving tamoxifen and megoestrol acetate. J Obstet Gynaecol 17:309–310CrossRefPubMedGoogle Scholar
  17. 17.
    Karim RZ, Russell P (2003) Test and teach. Diagnosis: benign metaplastic papillary change in an endometrial polyp. Pathology 35:522–525CrossRefPubMedGoogle Scholar
  18. 18.
    Park CK, Yoon G, Cho YA, Kim HS (2016) Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: a single institutional experience. Oncotarget 7:39197–39206PubMedPubMedCentralGoogle Scholar
  19. 19.
    Rekhi B, Menon S, Maheshwari A (2015) Complex papillary hyperplasia of the endometrium: an uncommon case report with cytopathological features and diagnostic implications. Diagn Cytopathol 43:163–168CrossRefPubMedGoogle Scholar
  20. 20.
    Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Cappellari JO, Bitterman P (1998) Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol 22:1379–1385CrossRefPubMedGoogle Scholar
  21. 21.
    Murray SK, Young RH, Scully RE (2000) Uterine endometrioid carcinoma with small nonvillous papillae: an analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma. Int J Surg Pathol 8:279–289CrossRefPubMedGoogle Scholar
  22. 22.
    Zaman SS, Mazur MT (1993) Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol 99:741–745CrossRefPubMedGoogle Scholar
  23. 23.
    Shah SS, Mazur MT (2008) Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process. Int J Gynecol Pathol 27:534–538CrossRefPubMedGoogle Scholar
  24. 24.
    Clement PB, Young RH. Nonneoplastic lesions of the uterine corpus. In: Atlas of gynecologic surgical pathology. 3rd ed. Philadelphia: W.B. Saunders; 2014. p. 148–175.Google Scholar
  25. 25.
    Arias-Stella J (2002) The Arias-Stella reaction: facts and fancies four decades after. Adv Anat Pathol 9:12–23CrossRefPubMedGoogle Scholar
  26. 26.
    Rosai J, Young RH (2015) Javier Arias-Stella and his famous reaction. Int J Gynecol Pathol 34:314–322CrossRefPubMedGoogle Scholar
  27. 27.
    Huettner PC, Gersell DJ (1994) Arias-Stella reaction in nonpregnant women: a clinicopathologic study of nine cases. Int J Gynecol Pathol 13:241–247CrossRefPubMedGoogle Scholar
  28. 28.
    Arias-Stella J (1972) Atypical endometrial changes produced by chorionic tissue. Hum Pathol 3:450–453CrossRefGoogle Scholar
  29. 29.
    Holmes EJ, Lyle WH (1973) How early in pregnancy does the Arias-Stella reaction occur? Arch Pathol 95:302–303PubMedGoogle Scholar
  30. 30.
    Mazur MT, Hendrickson MR, Kempson RL (1983) Optically clear nuclei. An alteration of endometrial epithelium in the presence of trophoblast. Am J Surg Pathol 7:415–423CrossRefPubMedGoogle Scholar
  31. 31.
    McCormick CJ, Menai-Williams RA (1995) Tripolar mitotic figures occurring in an Arias-Stella reaction within an endocervical polyp. Histopathology 26:575–576CrossRefPubMedGoogle Scholar
  32. 32.
    Lipper S, Benson JD (1981) Mitoses in the Arias-Stella reaction. Arch Pathol Lab Med 105:116–117PubMedGoogle Scholar
  33. 33.
    Yamani F, Fadare O (2016) Arias-Stella reaction in progestin-treated endometrioid adenocarcinoma: a potential diagnostic pitfall. Int J Surg Pathol 24:330–331CrossRefPubMedGoogle Scholar
  34. 34.
    Vang R, Barner R, Wheeler DT, Strauss BL (2004) Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma. Int J Gynecol Pathol 23:223–233CrossRefPubMedGoogle Scholar
  35. 35.
    Lim D, Ip PP, Cheung AN, Kiyokawa T, Oliva E (2015) Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma. Am J Surg Pathol 39:1061–1069CrossRefPubMedGoogle Scholar
  36. 36.
    Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Parkash V, Hecht JL (2014) Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. Am J Surg Pathol 38:189–196CrossRefPubMedGoogle Scholar
  37. 37.
    Fadare O (2016) Expression of Napsin A is common in Arias-Stella reaction. Hum Pathol 54:202CrossRefPubMedGoogle Scholar
  38. 38.
    Tresserra F, Lopez-Yarto M, Grases PJ, Ubeda A, Pascual MA, Labastida R (2003) Endometrial hyperplasia with secretory changes. Gynecol Oncol 88:386–393CrossRefPubMedGoogle Scholar
  39. 39.
    Bell CD, Ostrezega E (1987) The significance of secretory features and coincident hyperplastic changes in endometrial biopsy specimens. Hum Pathol 18:830–838CrossRefPubMedGoogle Scholar
  40. 40.
    Wheeler DT, Bristow RE, Kurman RJ (2007) Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31:988–998CrossRefPubMedGoogle Scholar
  41. 41.
    Tobon H, Watkins GJ (1985) Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 4:328–335CrossRefPubMedGoogle Scholar
  42. 42.
    Truskinovsky AM, Lifschitz-Mercer B, Czernobilsky B (2014) Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Int J Gynecol Pathol 33:107–113CrossRefPubMedGoogle Scholar
  43. 43.
    Gurda GT, Baras AS, Kurman RJ (2014) Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change. Int J Gynecol Pathol 33:114–119CrossRefPubMedGoogle Scholar
  44. 44.
    Kennedy MM, Baigrie CF, Manek S (1999) Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Int J Gynecol Pathol 18:130–137CrossRefPubMedGoogle Scholar
  45. 45.
    Dal Cin P, Vanni R, Marras S, Moerman P, Kools P, Andria M, Valdes E, Deprest J, Van de Ven W, Van den Berghe H (1995) Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 55:1565–1568PubMedGoogle Scholar
  46. 46.
    Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, Van Den Berghe H, Dal CP (2000) HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Investig 80:359–369CrossRefPubMedGoogle Scholar
  47. 47.
    Kim KR, Peng R, Ro JY, Robboy SJ (2004) A diagnostically useful histopathologic feature of endometrial polyp: the long axis of endometrial glands arranged parallel to surface epithelium. Am J Surg Pathol 28:1057–1062CrossRefPubMedGoogle Scholar
  48. 48.
    Hattab EM, Allam-Nandyala P, Rhatigan RM (1999) The stromal component of large endometrial polyps. Int J Gynecol Pathol 18:332–337CrossRefPubMedGoogle Scholar
  49. 49.
    Seto MT, Ip PP, Ngu SF, Cheung AN, Pun TC (2016) Positive predictive value of endometrial polyps in Pipelle aspiration sampling: a histopathological study of 195 cases. Eur J Obstet Gynecol Reprod Biol 203:12–15CrossRefPubMedGoogle Scholar
  50. 50.
    Tai LH, Tavassoli FA (2002) Endometrial polyps with atypical (bizarre) stromal cells. Am J Surg Pathol 26:505–509CrossRefPubMedGoogle Scholar
  51. 51.
    Heller D, Barrett T (2016) Bizarre stromal cells in an endometrial polyp. Int J Surg Pathol 24:320–321CrossRefPubMedGoogle Scholar
  52. 52.
    Howitt BE, Quade BJ, Nucci MR (2015) Uterine polyps with features overlapping with those of Mullerian adenosarcoma: a clinicopathologic analysis of 29 cases emphasizing their likely benign nature. Am J Surg Pathol 39:116–126CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PathologyThe University of Hong KongPok Fu LamHong Kong SAR

Personalised recommendations